Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan.
J Formos Med Assoc
; 120(3): 983-990, 2021 Mar.
Article
in En
| MEDLINE
| ID: mdl-32891488
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis C, Chronic
Type of study:
Guideline
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
J Formos Med Assoc
Journal subject:
MEDICINA
Year:
2021
Type:
Article
Affiliation country:
Taiwan